128 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

« prev | Page of 3 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
GAAGlucosidase, alpha; acidDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
GGPS1Geranylgeranyl diphosphate synthase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GSRGlutathione reductaseCancer-related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
GSSGlutathione synthetaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC3Histone deacetylase 3Enzymes
FDA approved drug targets
Expressed in all
HDAC6Histone deacetylase 6Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Group enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMP11Matrix metallopeptidase 11 (stromelysin 3)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MUTMethylmalonyl CoA mutaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
NNMTNicotinamide N-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
NOS3Nitric oxide synthase 3 (endothelial cell)Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
PAHPhenylalanine hydroxylaseDisease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
PDE5APhosphodiesterase 5A, cGMP-specificEnzymes
FDA approved drug targets
Expressed in all
PDE7APhosphodiesterase 7AEnzymes
FDA approved drug targets
Predicted secreted proteins
Expressed in all
PDE8APhosphodiesterase 8AEnzymes
FDA approved drug targets
Expressed in all
PDE8BPhosphodiesterase 8BDisease related genes
Enzymes
FDA approved drug targets
Tissue enriched
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PLA2G1BPhospholipase A2, group IB (pancreas)Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
PLA2G4APhospholipase A2, group IVA (cytosolic, calcium-dependent)Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Mixed
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PNLIPPancreatic lipaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched

« prev | Page of 3 | next »